| Preliminary analysis of FOLFIRI regimen with or without bevacizumab as second-line systemic therapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma. | |
| Zhao, Xiaoying; Wang, Chen Chen; Zhang, Wen; Zhu, Xiaodong; Guo, Weijian; Chen, Zhi-Yu | |
| 2017 | |
| 卷号 | 35 |
| 期号 | 4 |
| 会议录 | JOURNAL OF CLINICAL ONCOLOGY
 |
| 语种 | 英语 |
| URL标识 | 查看原文 |
| ISSN号 | 0732-183X |
| 内容类型 | 会议论文 |
| URI标识 | http://www.corc.org.cn/handle/1471x/3617289 |
| 专题 | 复旦大学上海医学院 |
| 推荐引用方式 GB/T 7714 | Zhao, Xiaoying,Wang, Chen Chen,Zhang, Wen,et al. Preliminary analysis of FOLFIRI regimen with or without bevacizumab as second-line systemic therapy in patients with metastatic gastroenteropancreatic neuroendocrine carcinoma.[C]. 见:. |
| 个性服务 |
| 查看访问统计 |
| 相关权益政策 |
| 暂无数据 |
| 收藏/分享 |
除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。
修改评论